India Set To Impose New Rules On Key Imported Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Indian government is nearing completion of a set of standards to use in ensuring the prices charged for critical drugs by multinational drug makers are under control. The government considers some of the prices for imported drugs to treat arthritis, diabetes, cancer, heart disease and obesity too high even if they are covered by the government's price control system. The new standards would allow the government to negotiate for certain drugs based on prices charged in other markets. (Click here for more
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.